We are live on ! Find out more
PA

Perceptive Advisors Portfolio holdings

AUM $6.66B
1-Year Est. Return 360.84%
This Fund
S&P 500
This Quarter Est. Return
+59.82%
1 Year Est. Return
+360.84%
3 Year Est. Return
+1,707.27%
5 Year Est. Return
+3,210.42%
10 Year Est. Return
+53,055.89%
AUM
$1.55B
AUM Growth
+$107M
Cap. Flow
-$72.8M
Cap. Flow %
-4.7%
Top 10 Hldgs %
49.99%
Holding
236
New
61
Increased
26
Reduced
57
Closed
43

Top Buys

Rank Stock Value
1
KDMN
Kadmon Holdings, Inc.
KDMN
+$20.1M
2
AVDL
Avadel Pharmaceuticals
AVDL
+$17.8M
3
RDUS
Radius Health, Inc.
RDUS
+$15.9M
4
ARAV
Aravive, Inc. Common Stock
ARAV
+$14.4M
5
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
+$13.6M

Top Sells

Rank Stock Value
1
MDVN
MEDIVATION, INC.
MDVN
+$45.8M
2
TSRO
TESARO, Inc.
TSRO
+$43.1M
3
NVRO
NEVRO CORP.
NVRO
+$31.9M
4
CPXX
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
+$25.3M
5
STJ
St Jude Medical
STJ
+$18.2M

Sector Composition

Rank Sector Weight
1 Healthcare 96.62%
2 Miscellaneous 2.58%
3 Consumer Staples 0.5%
4 Technology 0.1%
5 Consumer Discretionary 0.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LCTX icon
201
Lineage Cell Therapeutics
LCTX
$268M
– –
-15,705
Closed -$36K
LPCN icon
202
CALL
Lipocine
LPCN
$18.1M
– –
-17,647
Closed -$912K
LPCN icon
203
PUT
Lipocine
LPCN
$18.1M
– –
-16,729
Closed -$865K
LXRX icon
204
Lexicon Pharmaceuticals
LXRX
$894M
– –
-50,000
Closed -$718K
MCRB icon
205
Seres Therapeutics
MCRB
$46.2M
– –
-77
Closed -$45K
NVAX icon
206
Novavax
NVAX
$1.52B
– –
-1,600
Closed -$233K
SRPT icon
207
CALL
Sarepta Therapeutics
SRPT
$2.19B
– –
-979,200
Closed -$18.7M
SRPT icon
208
PUT
Sarepta Therapeutics
SRPT
$2.19B
– –
-7,619,300
Closed -$145M
TCRT icon
209
Alaunos Therapeutics
TCRT
$3.58M
– –
-7
Closed -$5K
TEVA icon
210
Teva Pharmaceuticals
TEVA
$45.7B
– –
-196,000
Closed -$9.85M
VYGR icon
211
Voyager Therapeutics
VYGR
$190M
– –
-650
Closed -$7K
XBI icon
212
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.4B
– –
-500,000
Closed -$27M
IMGN
213
DELISTED
Immunogen Inc
IMGN
– –
-25,745
Closed -$79K
ISEE
214
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
– –
-8,145
Closed -$459K
SIOX
215
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
– –
-60,625
Closed -$6.23M
AIMT
216
DELISTED
Aimmune Therapeutics
AIMT
– –
-6,448
Closed -$70K
PGNX
217
PUT
DELISTED
Progenics Pharmaceuticals Inc
PGNX
– –
-500,000
Closed -$2.11M
DPLO
218
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
– –
-2,175
Closed -$76K
PETX
219
DELISTED
Aratana Therapeutics, Inc.
PETX
– –
-256,500
Closed -$1.62M
GNCA
220
DELISTED
Genocea Biosciences, Inc.
GNCA
– –
-2,164
Closed -$71K
TSRO
221
PUT
DELISTED
TESARO, Inc.
TSRO
– –
-50,000
Closed -$4.2M
JUNO
222
DELISTED
Juno Therapeutics, Inc.
JUNO
– –
-1,113
Closed -$43K
ZLTQ
223
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
– –
-2,638
Closed -$72K
STJ
224
DELISTED
St Jude Medical
STJ
– –
-233,000
Closed -$18.2M
RLYP
225
PUT
DELISTED
RELYPSA INC COM
RLYP
– –
-100,000
Closed -$1.85M
6 7 8
9
10

Similar funds

QP
Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return
FCBT
First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return
RWM
Ritholtz Wealth Management New York $6.7B AUM 32.7% 1-Year Est. Return
AWA
Arkadios Wealth Advisors Atlanta, Georgia $6.6B AUM 30.67% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.59B AUM 31.9% 1-Year Est. Return
KGA
K5 Global Advisor Miami Beach, Florida $6.59B AUM
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $6.74B AUM 30.22% 1-Year Est. Return

Perceptive Advisors's Q3 2016 Portfolio in Review

As of Q3 2016, Perceptive Advisors held 236 positions worth $1.55B, up 7.4% from $1.44B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Perceptive Advisors withdrew a net $72.8M in Q3 2016, closing 43 positions and reducing 57 holdings. Its most notable exit was MEDIVATION, INC., an estimated $45.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 97% of assets, up from 79% a quarter earlier, followed by Miscellaneous and Consumer Staples.

Against the trend, Perceptive Advisors opened a new position in Kadmon Holdings, Inc. worth $16.2M.

  • Perceptive Advisors's largest Q3 2016 buy was Kadmon Holdings, Inc.: 2,209,657 shares worth $16.2M.
  • Perceptive Advisors added most to Aravive, Inc. Common Stock in Q3 2016, an estimated $14.4M increase.
  • Perceptive Advisors's biggest Q3 2016 reduction was TESARO, Inc., cutting an estimated $43.1M.
  • Perceptive Advisors fully exited MEDIVATION, INC. in Q3 2016, selling an estimated $45.8M.
  • Perceptive Advisors's ten largest holdings make up 50% of its $1.55B portfolio in Q3 2016.
  • Perceptive Advisors opened 61 new positions and closed 43 in Q3 2016.
  • Perceptive Advisors's portfolio value rose 7.4% quarter-over-quarter to $1.55B.

Based on Perceptive Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.